Market Highlights: Bristol-Myers Squibb Co. (BMY) Ends on a High Note at 44.94

In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.

The price of Bristol-Myers Squibb Co. (NYSE: BMY) closed at $44.94 in the last session, up 0.45% from day before closing price of $44.74. In other words, the price has increased by $0.45 from its previous closing price. On the day, 8.68 million shares were traded. BMY stock price reached its highest trading level at $44.97 during the session, while it also had its lowest trading level at $44.3.


We take a closer look at BMY’s different ratios to gain a better understanding of the stock. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 9.42 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 7.28. For the most recent quarter (mrq), Quick Ratio is recorded 0.99 and its Current Ratio is at 1.11. In the meantime, Its Debt-to-Equity ratio is 3.48 whereas as Long-Term Debt/Eq ratio is at 3.10.

On February 06, 2024, Redburn Atlantic Downgraded its rating to Neutral which previously was Buy and also lowered its target price recommendation from $77 to $54.

BofA Securities Downgraded its Buy to Neutral on January 03, 2024, whereas the target price for the stock was revised from $68 to $60.

Insider Transactions:

An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Dec 05 ’23 when BOERNER CHRISTOPHER S. bought 2,000 shares for $49.78 per share. The transaction valued at 99,560 led to the insider holds 82,672 shares of the business.

BOERNER CHRISTOPHER S. bought 3,071 shares of BMY for $150,049 on Nov 28 ’23. The Chief Executive Officer now owns 79,384 shares after completing the transaction at $48.86 per share. On Nov 20 ’23, another insider, Samuels Theodore R. II, who serves as the Director of the company, bought 8,500 shares for $49.81 each. As a result, the insider paid 423,385 and bolstered with 35,500 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, BMY now has a Market Capitalization of 91097874432 and an Enterprise Value of 138942873600. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.00 while its Price-to-Book (P/B) ratio in mrq is 5.52. Its current Enterprise Value per Revenue stands at 3.051 whereas that against EBITDA is 7.646.

Stock Price History:

The Beta on a monthly basis for BMY is 0.45, which has changed by -0.3407657 over the last 52 weeks, in comparison to a change of 0.26265144 over the same period for the S&P500. Over the past 52 weeks, BMY has reached a high of $69.10, while it has fallen to a 52-week low of $43.33. The 50-Day Moving Average of the stock is -9.70%, while the 200-Day Moving Average is calculated to be -15.61%.

Shares Statistics:

According to the various share statistics, BMY traded on average about 15.42M shares per day over the past 3-months and 12700180 shares per day over the past 10 days. A total of 2.03B shares are outstanding, with a floating share count of 2.03B. Insiders hold about 0.08% of the company’s shares, while institutions hold 79.90% stake in the company. Shares short for BMY as of 1714435200 were 28024749 with a Short Ratio of 1.82, compared to 1711584000 on 35116032. Therefore, it implies a Short% of Shares Outstanding of 28024749 and a Short% of Float of 1.38.

Dividends & Splits

The forward annual dividend rate for BMY is 2.34, which was 2.34 in the trailing 12 months. Against a Trailing Annual Dividend Yield of 0.052302185The stock’s 5-year Average Dividend Yield is 3.25. The current Payout Ratio is 59.82% for BMY, which recently paid a dividend on 2024-04-04 with an ex-dividend date of 1712188800. Stock splits for the company last occurred on 2001-08-07 when the company split stock in a 1000000:951777 ratio.

Earnings Estimates

The firm’s stock currently is rated by 16.0 analysts. On average, analysts expect EPS of $1.7 for the current quarter, with a high estimate of $2.05 and a low estimate of $1.55, while EPS last year was $1.75. The consensus estimate for the next quarter is $1.64, with high estimates of $1.72 and low estimates of $1.56.

Analysts are recommending an EPS of between $0.67 and $0.36 for the fiscal current year, implying an average EPS of $0.56. EPS for the following year is $6.92, with 22.0 analysts recommending between $7.69 and $6.27.

Revenue Estimates

For the next quarter, 15 analysts are estimating revenue of $11.19B. There is a high estimate of $11.52B for the next quarter, whereas the lowest estimate is $10.97B.

A total of 23 analysts have provided revenue estimates for BMY’s current fiscal year. The highest revenue estimate was $46.88B, while the lowest revenue estimate was $45.28B, resulting in an average revenue estimate of $46.1B. In the same quarter a year ago, actual revenue was $42.04BBased on 23 analysts’ estimates, the company’s revenue will be $46.12B in the next fiscal year. The high estimate is $47.77B and the low estimate is $42.68B.

Most Popular

[the_ad id="945"]